Indonesia
Industry
BMI Core View: Drugmakers based in emerging markets will increasingly produce hard-to-manufacture pharmaceuticals. Firms in developing countries enjoy low operating costs but have traditionally...
2010-07-19Industry
BMI has revised upwards its forecast for Indonesia's pharmaceutical market following the receipt of confirmed 2009 data. According to local drugmaker PT Kalbe Farma, total sales of...
2010-03-30Industry
Indonesia is expected to implement its long-awaited National Social Security System (Sistem Jaminan Sosial Nasional; SJSN) Law of 2004 later this year. By rationalising existing schemes...
2010-01-26Industry
In a bid to boost drug sales in certain emerging markets, multinational drugmaker Sanofi-Aventis has cut the prices of some of its drugs by as much as 50% in the Philippines and Indonesia....
2010-01-14Industry
Corruption is endemic in Indonesia's healthcare system. Patients frequently pay bribes to receive treatment, numerous layers of bureaucracy consume resources and drugmakers are frustrated...
2009-12-14Industry
One of BMI's core views for the pharmaceuticals and healthcare industry is that emerging markets will drive global medicine sales. However, not all drugmakers subscribe to this opinion....
2009-09-17Industry
Indonesia has become the latest heavily-populated country to announce healthcare reforms. At the presidential palace, recently re-elected Susilo Bambang Yudhoyono stressed his commitment...
2009-09-16Industry
Direct-to-consumer (DTC) advertising of pharmaceuticals is only permitted in the US and New Zealand. Other countries have determined that this practice encourages 'disease mongering'...
2009-08-14
